SCHEMBL7946664

SCHEMBL7946664

CC(=O)c1cc(-c2cccnc2)n2c1CCCC2

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 11/20 0.43
CYP11B1 P15538 4/20 0.43
CYP2C9 P11712 2/20 0.40
TP53 P04637 1/20 0.40
AVPR2 P30518 1/20 0.40
OXTR P30559 1/20 0.40
AVPR1A P37288 1/20 0.40
WNT1 P04628 2/20 0.39
DYRK1A Q13627 2/20 0.39
CLK2 P49760 1/20 0.39
CLK3 P49761 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP2C19 P33261 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7953705 0.89 CYP2C9 (0.43) CYP11B2CYP11B1CYP2C9AVPR2OXTR
SCHEMBL2157288 0.88 MKNK1 (0.46) CYP11B2CYP2C9AVPR2OXTRAVPR1A
SCHEMBL7954905 0.87 NR4A2 (0.46) CYP11B2CYP11B1TP53
SCHEMBL10742663 0.87 MKNK1 (0.45) CYP11B2CYP11B1CYP2C9WNT1DYRK1A
Hydrochloric Acid SCHEMBL10742608 0.87 CYP2C9 (0.39) CYP11B2CYP11B1CYP2C9AVPR2OXTR
SCHEMBL7946521 0.85 KMO (0.46) CYP11B2CYP11B1CYP2C9
SCHEMBL7953665 0.84 MKNK1 (0.47) CYP11B2
SCHEMBL10737507 0.83 CYP11B2 (0.47) CYP11B2CYP11B1WNT1DYRK1ACYP3A4
Hydrochloric Acid SCHEMBL10737389 0.83 CYP11B2 (0.41) CYP11B2CYP11B1CYP2C9
SCHEMBL7954951 0.82 HDAC3 (0.38) CYP11B2CYP11B1CYP2C9TP53AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194426-B1 CONTROLLING TUMOR NECROSIS FACTOR RHONA-POULENC RORER S.A. (FR) 2001-02-27 US claimed
EP-0833635-A1 NOVEL USE FOR PYRROLE DERIVATIVES Aventis Pharma S.A. (FR) 1998-04-08 EP claimed
WO-1997000073-A1 NOVEL USE FOR PYRROLE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1997-01-03 WO claimed
US-6194426-B1 CONTROLLING TUMOR NECROSIS FACTOR RHONA-POULENC RORER S.A. (FR) 2001-02-27 US disclosed
EP-0833635-A1 NOVEL USE FOR PYRROLE DERIVATIVES Aventis Pharma S.A. (FR) 1998-04-08 EP disclosed
WO-1997000073-A1 NOVEL USE FOR PYRROLE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1997-01-03 WO disclosed